Skip to content
Search

Latest Stories

Covid-19 cost claims: Less than three weeks left for contractors

The Pharmaceutical Services Negotiating Committee (PSNC) will host a second Covid-19 cost claims workshop for community pharmacy contractors on Monday (August 2) at 7.30 pm.

During the online workshop, PSNC’s CEO and Director of Pharmacy Funding will explain the deal reached with HM government, describe the NHSBSA claiming process, and work through some examples.


Community pharmacy contractors have less than three weeks left to claim for the extra costs they incurred due to the Covid-19 pandemic.

Under the deal reached between PSNC and HM government, Covid-19 cost claims must be made between 5th July and 15th August 2021 using an agreed claim form provided by the NHS Business Services Authority (NHSBSA), and payments will be made on 1st October 2021.

Contractors can claim for specific categories of Covid-19 related costs incurred between 1st March 2020 and 31st March 2021 for the delivery of NHS pharmaceutical services.

The NHSBSA claim form asks contractors to set out their costs according to these categories and to indicate the evidence they have for them.

The Department of Health and Social Care (DHSC) has not set out detailed evidence requirements so this will need careful thought, particularly as contractors will also need to provide documentation to evidence their claims should the NHSBSA ask to see it.

"It is important that no contractor misses out on this opportunity, so please begin thinking about your Covid-19 costs and gathering evidence for them as soon as possible so you have adequate time to complete the claim form," said PSNC.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less